Company intelligence / Profile preview

MedChemExpress

Monmouth Junction, New Jersey, United Statesmedchemexpress.com ↗

Ownership: Private
Employees: ~94
Development stage: Commercial

Overview

MedChemExpress does not have its own clinical pipeline or results. The company’s products are widely cited in scientific publications (>30,000) and used globally by academic labs and industry researchers for biomedical discovery.

Therapeutic areas: OncologyImmunologyCardiovascularNeurology
Modalities: Small moleculePeptidesRecombinant proteinAntibody-drug conjugateOligonucleotideCytokineNatural productAntibody fragment (recombinant)Protein (general)
Industry: Chemicals & Materials

Drug pipeline

2 assets

KH-4-43

Pre-clinical

Indications: Ovarian cancer

1 more asset in the full pipeline.

Partnerships

Over 500+ global partners including academic institutions and biotech/pharma companies as customers/distributors. No major co-development partnerships reported.

Beyond the preview

Go deeper on MedChemExpress.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedChemExpress.